Cardiff Lexington Corp. Amends 2023 10-K Filing

Ticker: CDIX · Form: 10-K/A · Filed: Aug 8, 2024 · CIK: 811222

Cardiff Lexington CORP 10-K/A Filing Summary
FieldDetail
CompanyCardiff Lexington CORP (CDIX)
Form Type10-K/A
Filed DateAug 8, 2024
Risk Levellow
Pages15
Reading Time18 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: amendment, financials, 10-K

TL;DR

Cardiff Lexington Corp. just amended its 2023 10-K. Financials updated.

AI Summary

Cardiff Lexington Corp. filed Amendment #3 to its 2023 Form 10-K on August 8, 2024, to amend its financial statements for the fiscal year ending December 31, 2023. The company, formerly known as Cardiff International Inc., is incorporated in Florida and headquartered in Las Vegas, Nevada.

Why It Matters

This amendment indicates that Cardiff Lexington Corporation is correcting or updating previously filed financial information for the 2023 fiscal year, which could impact investor understanding of the company's financial health.

Risk Assessment

Risk Level: low — This filing is an amendment to a previous filing and does not introduce new material risks.

Key Numbers

Key Players & Entities

FAQ

What specific financial information is being amended in the 2023 10-K?

The filing indicates it is an amendment to the financial statements for the fiscal year ended December 31, 2023, but does not specify the exact nature of the amendments within the provided text.

What was Cardiff Lexington Corp. previously known as?

Cardiff Lexington Corp. was formerly known as Cardiff International Inc., United American Inc., and Cardiff Financial Inc.

When was the original 2023 10-K filed?

The original 2023 10-K was filed as of December 31, 2023, with the filing date likely around March 2024, though this specific date is not in the provided text.

What is the business address of Cardiff Lexington Corp.?

The business address is 3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV 89169.

What is the SIC code for Cardiff Lexington Corp.?

The Standard Industrial Classification (SIC) code is 8011, which corresponds to Services-Offices & Clinics of Doctors of Medicine.

Filing Stats: 4,517 words · 18 min read · ~15 pages · Grade level 16 · Accepted 2024-08-07 20:56:12

Key Financial Figures

Filing Documents

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations. 37 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk. 49 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data. 49 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. 49 Item 9A.

Controls and Procedures

Controls and Procedures. 49 Item 9B. Other Information. 51 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. 51 PART III Item 10. Directors, Executive Officers and Corporate Governance. 52 Item 11.

Executive Compensation

Executive Compensation. 55 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. 60 Item 13. Certain Relationships and Related Transactions, and Director Independence. 61 Item 14. Principal Accounting Fees and Services. 61 PART IV Item 15. Exhibit and Financial Statement Schedules. 62 Item 16. Form 10-K Summary. 64 i INTRODUCTORY NOTES Use of Terms Except as otherwise indicated by the context and for the purposes of this report only, references in this report to "we," "us," "our" and "our company" are to Cardiff Lexington Corporation, a Nevada corporation, and its consolidated subsidiaries. Special Note Regarding Forward-Looking Statements This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are based on our management's beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts are forward-looking statements. These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include, but are not limited to, statements about: our ability to successfully identify and acquire additional businesses; our ability to effectively integrate and operate the businesses that we acquire; our expectations around the performance of our current businesses; our ability to maintain our business model and improve our capital efficiency; our ability to effectively manage the growth of our business; our ability to maintain profitabil

View Full Filing

View this 10-K/A filing on SEC EDGAR

View on Read The Filing